IL2 and rheumatoid arthritis: In contrast, Carbone et al., revealed that there is no correlation between IL-6 and IL-17 where IL-6 inhibitor, Actemra, significantly decreases IL-6 and slightly decreases IL-2 but did not influence the IL-17 level in rheumatoid arthritis.